The director and the director emeritus of the Max Planck Institute of Biochemistry (MPIB) are receiving the award for their respective contributions to their fields of research.
more
Researchers at the MPI of Biochemistry and TUM have examined the cerebrospinal fluid of 5,000 patients with neurological diseases and discovered new diagnostic and prognostic markers for multiple sclerosis.
more
An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, opening a new avenue for targeted therapy.
more
Researchers at the MPI of Biochemistry have used spatial Deep Visual Proteomics workflow to reveal why some patients with the hereditary disease alpha-1 antitrypsin deficiency remain healthy despite the genetic defect.
more
